BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Scarpignato C. Piroxicam-β-cyclodextrin: a GI safer piroxicam. Curr Med Chem 2013;20:2415-37. [PMID: 23394552 DOI: 10.2174/09298673113209990115] [Cited by in Crossref: 23] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
Number Citing Articles
1 Dwivedi AK, Gurjar V, Kumar S, Singh N. Molecular basis for nonspecificity of nonsteroidal anti-inflammatory drugs (NSAIDs). Drug Discov Today 2015;20:863-73. [PMID: 25794602 DOI: 10.1016/j.drudis.2015.03.004] [Cited by in Crossref: 35] [Cited by in F6Publishing: 27] [Article Influence: 5.0] [Reference Citation Analysis]
2 Durk MR, Jones NS, Liu J, Nagapudi K, Mao C, Plise EG, Wong S, Chen JZ, Chen Y, Chinn LW, Chiang PC. Understanding the Effect of Hydroxypropyl-β-Cyclodextrin on Fenebrutinib Absorption in an Itraconazole-Fenebrutinib Drug-Drug Interaction Study. Clin Pharmacol Ther 2020;108:1224-32. [PMID: 32535897 DOI: 10.1002/cpt.1943] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Liu X, Michalchuk AAL, Pulham CR, Boldyreva EV. An acetonitrile-solvated cocrystal of piroxicam and succinic acid with co-existing zwitterionic and non-ionized piroxicam molecules. Acta Crystallogr C Struct Chem 2019;75:29-37. [PMID: 30601128 DOI: 10.1107/S2053229618016911] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
4 Bach-Rojecky L, Vađunec D, Žunić K, Kurija J, Šipicki S, Gregg R, Mikula I, Primorac D. Continuing war on pain: a personalized approach to the therapy with nonsteroidal anti-inflammatory drugs and opioids. Per Med 2019;16:171-84. [PMID: 30484741 DOI: 10.2217/pme-2018-0116] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
5 Chantasart D, Tocanitchart P, Wongrakpanich A, Teeranachaideekul V, Junyaprasert VB. Fabrication and evaluation of Eudragit® polymeric films for transdermal delivery of piroxicam. Pharm Dev Technol 2018;23:771-9. [PMID: 28406344 DOI: 10.1080/10837450.2017.1319864] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
6 de Bruin N, Schneider A, Reus P, Talmon S, Ciesek S, Bojkova D, Cinatl J, Lodhi I, Charlesworth B, Sinclair S, Pennick G, Laughey WF, Gribbon P, Kannt A, Schiffmann S. Ibuprofen, Flurbiprofen, Etoricoxib or Paracetamol Do Not Influence ACE2 Expression and Activity In Vitro or in Mice and Do Not Exacerbate In-Vitro SARS-CoV-2 Infection. IJMS 2022;23:1049. [DOI: 10.3390/ijms23031049] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Du JJ, Váradi L, Williams PA, Groundwater PW, Overgaard J, Platts JA, Hibbs DE. An analysis of the experimental and theoretical charge density distributions of the piroxicam–saccharin co-crystal and its constituents. RSC Adv 2016;6:81578-90. [DOI: 10.1039/c6ra10411h] [Cited by in Crossref: 15] [Article Influence: 2.5] [Reference Citation Analysis]
8 de Oliveira Makson G, Guimarães AG, Araújo Adriano A, Quintans Jullyana S, Santos MR, Quintans-júnior LJ. Cyclodextrins: improving the therapeutic response of analgesic drugs: a patent review. Expert Opinion on Therapeutic Patents 2015;25:897-907. [DOI: 10.1517/13543776.2015.1045412] [Cited by in Crossref: 41] [Cited by in F6Publishing: 36] [Article Influence: 5.9] [Reference Citation Analysis]
9 Tamasi G, Bernini C, Corbini G, Owens NF, Messori L, Scaletti F, Massai L, Giudice PL, Cini R. Synthesis, spectroscopic and DFT structural characterization of two novel ruthenium(III) oxicam complexes. In vivo evaluation of anti-inflammatory and gastric damaging activities. Journal of Inorganic Biochemistry 2014;134:25-35. [DOI: 10.1016/j.jinorgbio.2014.01.011] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
10 Scavone C, Bonagura AC, Fiorentino S, Cimmaruta D, Cenami R, Torella M, Fossati T, Rossi F. Efficacy and Safety Profile of Diclofenac/Cyclodextrin and Progesterone/Cyclodextrin Formulations: A Review of the Literature Data. Drugs R D 2016;16:129-40. [PMID: 26939533 DOI: 10.1007/s40268-016-0123-2] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 3.6] [Reference Citation Analysis]
11 Brito RG, Araújo AA, Quintans JS, Sluka KA, Quintans-Júnior LJ. Enhanced analgesic activity by cyclodextrins - a systematic review and meta-analysis. Expert Opin Drug Deliv 2015;12:1677-88. [PMID: 26159048 DOI: 10.1517/17425247.2015.1046835] [Cited by in Crossref: 40] [Cited by in F6Publishing: 37] [Article Influence: 5.7] [Reference Citation Analysis]
12 Iqbal A, Zaman M, Wahab Amjad M, Adnan S, Abdul Ghafoor Raja M, Haider Rizvi SF, Mustafa MW, Farooq U, Abbas G, Shah S. Solid Lipid Nanoparticles of Mycophenolate Mofetil: An Attempt to Control the Release of an Immunosuppressant. Int J Nanomedicine 2020;15:5603-12. [PMID: 32848390 DOI: 10.2147/IJN.S255636] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Vicatos AI, Caira MR. Cyclodextrin complexes of the anticonvulsant agent valproic acid. CrystEngComm 2021;23:6582-90. [DOI: 10.1039/d1ce01024g] [Reference Citation Analysis]
14 Maestrelli F, Bragagni M, Mura P. Advanced formulations for improving therapies with anti-inflammatory or anaesthetic drugs: A review. Journal of Drug Delivery Science and Technology 2016;32:192-205. [DOI: 10.1016/j.jddst.2015.09.011] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
15 Mostafa GAE, Al-Dosseri AS, Al-Badr AA. Piroxicam. Profiles Drug Subst Excip Relat Methodol 2020;45:199-474. [PMID: 32164968 DOI: 10.1016/bs.podrm.2019.10.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
16 Upadhyay RK. Drug delivery systems, CNS protection, and the blood brain barrier. Biomed Res Int 2014;2014:869269. [PMID: 25136634 DOI: 10.1155/2014/869269] [Cited by in Crossref: 130] [Cited by in F6Publishing: 133] [Article Influence: 16.3] [Reference Citation Analysis]
17 Gilani S, Mir S, Masood M, Khan AK, Rashid R, Azhar S, Rasul A, Ashraf MN, Waqas MK, Murtaza G. Triple-component nanocomposite films prepared using a casting method: Its potential in drug delivery. J Food Drug Anal 2018;26:887-902. [PMID: 29567261 DOI: 10.1016/j.jfda.2017.02.006] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 2.2] [Reference Citation Analysis]